Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 57 entries
Sorted by: Best Match Show Resources per page
Key Recent Advances in Atherosclerosis Treatment with Modern Lipid-lowering Drugs: The New Frontier with PCSK9 Inhibitors.

European cardiology

Martínez-Rubio A, Freixa Pamias R.
PMID: 30416548
Eur Cardiol. 2017 Aug;12(1):30-32. doi: 10.15420/ecr.2017.12.1.GE3.

No abstract available.

Cite
Martínez-Rubio A, Freixa Pamias R. Key Recent Advances in Atherosclerosis Treatment with Modern Lipid-lowering Drugs: The New Frontier with PCSK9 Inhibitors. Eur Cardiol. 2017;12(1):30-32doi: 10.15420/ecr.2017.12.1.GE3.
Martínez-Rubio, A., & Freixa Pamias, R. (2017). Key Recent Advances in Atherosclerosis Treatment with Modern Lipid-lowering Drugs: The New Frontier with PCSK9 Inhibitors. European cardiology, 12(1), 30-32. https://doi.org/10.15420/ecr.2017.12.1.GE3
Martínez-Rubio, Antoni, and Freixa Pamias, Román. "Key Recent Advances in Atherosclerosis Treatment with Modern Lipid-lowering Drugs: The New Frontier with PCSK9 Inhibitors." European cardiology vol. 12,1 (2017): 30-32. doi: https://doi.org/10.15420/ecr.2017.12.1.GE3
Martínez-Rubio A, Freixa Pamias R. Key Recent Advances in Atherosclerosis Treatment with Modern Lipid-lowering Drugs: The New Frontier with PCSK9 Inhibitors. Eur Cardiol. 2017 Aug;12(1):30-32. doi: 10.15420/ecr.2017.12.1.GE3. PMID: 30416548; PMCID: PMC6206462.
Copy Download .nbib Format: NLM
Oral Anticoagulation and Prognosis of Patients with Atrial Fibrillation After Ischemic Stroke: A Real-world Data Analysis.

European cardiology

Diaznuila-Alcázar M, Valcárcel-Paz D, Castillo-Vásquez PD, Santaló-Corcoy M, Bragagnini W, Oliva-Morera JC, Bosch-Peligero E, Martínez-Rubio A.
PMID: 30416565
Eur Cardiol. 2017 Dec;12(2):95. doi: 10.15420/ecr.2017:23:4.

No abstract available.

Cite
Diaznuila-Alcázar M, Valcárcel-Paz D, Castillo-Vásquez PD, et al. Oral Anticoagulation and Prognosis of Patients with Atrial Fibrillation After Ischemic Stroke: A Real-world Data Analysis. Eur Cardiol. 2017;12(2):95doi: 10.15420/ecr.2017:23:4.
Diaznuila-Alcázar, M., Valcárcel-Paz, D., Castillo-Vásquez, P. D., Santaló-Corcoy, M., Bragagnini, W., Oliva-Morera, J. C., Bosch-Peligero, E., & Martínez-Rubio, A. (2017). Oral Anticoagulation and Prognosis of Patients with Atrial Fibrillation After Ischemic Stroke: A Real-world Data Analysis. European cardiology, 12(2), 95. https://doi.org/10.15420/ecr.2017:23:4
Diaznuila-Alcázar, Mario, et al. "Oral Anticoagulation and Prognosis of Patients with Atrial Fibrillation After Ischemic Stroke: A Real-world Data Analysis." European cardiology vol. 12,2 (2017): 95. doi: https://doi.org/10.15420/ecr.2017:23:4
Diaznuila-Alcázar M, Valcárcel-Paz D, Castillo-Vásquez PD, Santaló-Corcoy M, Bragagnini W, Oliva-Morera JC, Bosch-Peligero E, Martínez-Rubio A. Oral Anticoagulation and Prognosis of Patients with Atrial Fibrillation After Ischemic Stroke: A Real-world Data Analysis. Eur Cardiol. 2017 Dec;12(2):95. doi: 10.15420/ecr.2017:23:4. PMID: 30416565; PMCID: PMC6213033.
Copy Download .nbib Format: NLM
Direct Experience While Eating in a Sample With Eating Disorders and Obesity.

Frontiers in psychology

Soler J, Cebolla A, Elices M, Campos D, Llorca G, Martínez-Rubio D, Martínez-Brotóns C, Jorquera M, Allirot X, Carmona C, Guillen V, Botella C, Baños RM.
PMID: 30245645
Front Psychol. 2018 Sep 07;9:1373. doi: 10.3389/fpsyg.2018.01373. eCollection 2018.

No abstract available.

Cite
Soler J, Cebolla A, Elices M, et al. Direct Experience While Eating in a Sample With Eating Disorders and Obesity. Front Psychol. 2018;9:1373doi: 10.3389/fpsyg.2018.01373.
Soler, J., Cebolla, A., Elices, M., Campos, D., Llorca, G., Martínez-Rubio, D., Martínez-Brotóns, C., Jorquera, M., Allirot, X., Carmona, C., Guillen, V., Botella, C., & Baños, R. M. (2018). Direct Experience While Eating in a Sample With Eating Disorders and Obesity. Frontiers in psychology, 91373. https://doi.org/10.3389/fpsyg.2018.01373
Soler, Joaquim, et al. "Direct Experience While Eating in a Sample With Eating Disorders and Obesity." Frontiers in psychology vol. 9 (2018): 1373. doi: https://doi.org/10.3389/fpsyg.2018.01373
Soler J, Cebolla A, Elices M, Campos D, Llorca G, Martínez-Rubio D, Martínez-Brotóns C, Jorquera M, Allirot X, Carmona C, Guillen V, Botella C, Baños RM. Direct Experience While Eating in a Sample With Eating Disorders and Obesity. Front Psychol. 2018 Sep 07;9:1373. doi: 10.3389/fpsyg.2018.01373. eCollection 2018. PMID: 30245645; PMCID: PMC6137958.
Copy Download .nbib Format: NLM
Case Report: ALCAPA syndrome: successful repair with an anatomical and physiological alternative surgical technique.

F1000Research

Vilá Mollinedo LG, Jaime Uribe A, Aceves Chimal JL, Martínez-Rubio RP, Hernández-Romero KP.
PMID: 27547381
F1000Res. 2016 Jul 13;5:1680. doi: 10.12688/f1000research.8823.1. eCollection 2016.

Anomalous left coronary artery from the pulmonary artery, or ALCAPA syndrome, is a rare congenital cardiac disease that can cause myocardial infarction, heart failure and even death in paediatric patients. Only few untreated patients survive until adult age. Here...

Cite
Vilá Mollinedo LG, Jaime Uribe A, Aceves Chimal JL, et al. Case Report: ALCAPA syndrome: successful repair with an anatomical and physiological alternative surgical technique. F1000Res. 2016;5:1680doi: 10.12688/f1000research.8823.1.
Vilá Mollinedo, L. G., Jaime Uribe, A., Aceves Chimal, J. L., Martínez-Rubio, R. P., & Hernández-Romero, K. P. (2016). Case Report: ALCAPA syndrome: successful repair with an anatomical and physiological alternative surgical technique. F1000Research, 51680. https://doi.org/10.12688/f1000research.8823.1
Vilá Mollinedo, Luis Gustavo, et al. "Case Report: ALCAPA syndrome: successful repair with an anatomical and physiological alternative surgical technique." F1000Research vol. 5 (2016): 1680. doi: https://doi.org/10.12688/f1000research.8823.1
Vilá Mollinedo LG, Jaime Uribe A, Aceves Chimal JL, Martínez-Rubio RP, Hernández-Romero KP. Case Report: ALCAPA syndrome: successful repair with an anatomical and physiological alternative surgical technique. F1000Res. 2016 Jul 13;5:1680. doi: 10.12688/f1000research.8823.1. eCollection 2016. PMID: 27547381.
Copy Download .nbib Format: NLM
"Oxygen Sensing" by Na,K-ATPase: These Miraculous Thiols.

Frontiers in physiology

Bogdanova A, Petrushanko IY, Hernansanz-Agustín P, Martínez-Ruiz A.
PMID: 27531981
Front Physiol. 2016 Aug 02;7:314. doi: 10.3389/fphys.2016.00314. eCollection 2016.

Control over the Na,K-ATPase function plays a central role in adaptation of the organisms to hypoxic and anoxic conditions. As the enzyme itself does not possess O2 binding sites its "oxygen-sensitivity" is mediated by a variety of redox-sensitive modifications...

Cite
Bogdanova A, Petrushanko IY, Hernansanz-Agustín P, et al. "Oxygen Sensing" by Na,K-ATPase: These Miraculous Thiols. Front Physiol. 2016;7:314doi: 10.3389/fphys.2016.00314.
Bogdanova, A., Petrushanko, I. Y., Hernansanz-Agustín, P., & Martínez-Ruiz, A. (2016). "Oxygen Sensing" by Na,K-ATPase: These Miraculous Thiols. Frontiers in physiology, 7314. https://doi.org/10.3389/fphys.2016.00314
Bogdanova, Anna, et al. ""Oxygen Sensing" by Na,K-ATPase: These Miraculous Thiols." Frontiers in physiology vol. 7 (2016): 314. doi: https://doi.org/10.3389/fphys.2016.00314
Bogdanova A, Petrushanko IY, Hernansanz-Agustín P, Martínez-Ruiz A. "Oxygen Sensing" by Na,K-ATPase: These Miraculous Thiols. Front Physiol. 2016 Aug 02;7:314. doi: 10.3389/fphys.2016.00314. eCollection 2016. PMID: 27531981; PMCID: PMC4970491.
Copy Download .nbib Format: NLM
Cuprizone does not induce CNS demyelination in nonhuman primates.

Annals of clinical and translational neurology

Chen Z, Chen JT, Johnson M, Gossman ZC, Hendrickson M, Sakaie K, Martinez-Rubio C, Gale JT, Trapp BD.
PMID: 25750925
Ann Clin Transl Neurol. 2015 Feb;2(2):208-13. doi: 10.1002/acn3.159. Epub 2014 Dec 18.

Cognitive decline is a common symptom in multiple sclerosis patients, with profound effects on the quality of life. A nonhuman primate model of multiple sclerosis would be best suited to test the effects of demyelination on complex cognitive functions...

Cite
Chen Z, Chen JT, Johnson M, et al. Cuprizone does not induce CNS demyelination in nonhuman primates. Ann Clin Transl Neurol. 2014;2(2):208-13doi: 10.1002/acn3.159.
Chen, Z., Chen, J. T., Johnson, M., Gossman, Z. C., Hendrickson, M., Sakaie, K., Martinez-Rubio, C., Gale, J. T., & Trapp, B. D. (2015). Cuprizone does not induce CNS demyelination in nonhuman primates. Annals of clinical and translational neurology, 2(2), 208-13. https://doi.org/10.1002/acn3.159
Chen, Zhihong, et al. "Cuprizone does not induce CNS demyelination in nonhuman primates." Annals of clinical and translational neurology vol. 2,2 (2015): 208-13. doi: https://doi.org/10.1002/acn3.159
Chen Z, Chen JT, Johnson M, Gossman ZC, Hendrickson M, Sakaie K, Martinez-Rubio C, Gale JT, Trapp BD. Cuprizone does not induce CNS demyelination in nonhuman primates. Ann Clin Transl Neurol. 2015 Feb;2(2):208-13. doi: 10.1002/acn3.159. Epub 2014 Dec 18. PMID: 25750925; PMCID: PMC4338961.
Copy Download .nbib Format: NLM
Use of plasma rich in growth factors (PRGF-Endoret®) fibrin membrane to cover corneal dellen.

Romanian journal of ophthalmology

Rahhal-Ortuño M, Fernández-Santodomingo AS, Martínez-Rubio C, Barranco-González H, Almor-Palacios I, Rodrigo-Hernández A.
PMID: 35036656
Rom J Ophthalmol. 2021 Jul-Sep;65(3):293-295. doi: 10.22336/rjo.2021.60.

Corneal dellen appeared as a complication after perilimbal conjunctival papilloma dissection in a six-year-old patient. Our purpose was to describe the use of plasma rich in growth factors (PRGF) fibrin membrane in covering the corneal defect after conventional medical...

Cite
Rahhal-Ortuño M, Fernández-Santodomingo AS, Martínez-Rubio C, et al. Use of plasma rich in growth factors (PRGF-Endoret®) fibrin membrane to cover corneal dellen. Rom J Ophthalmol. 2021;65(3):293-295doi: 10.22336/rjo.2021.60.
Rahhal-Ortuño, M., Fernández-Santodomingo, A. S., Martínez-Rubio, C., Barranco-González, H., Almor-Palacios, I., & Rodrigo-Hernández, A. (2021). Use of plasma rich in growth factors (PRGF-Endoret®) fibrin membrane to cover corneal dellen. Romanian journal of ophthalmology, 65(3), 293-295. https://doi.org/10.22336/rjo.2021.60
Rahhal-Ortuño, Miriam, et al. "Use of plasma rich in growth factors (PRGF-Endoret®) fibrin membrane to cover corneal dellen." Romanian journal of ophthalmology vol. 65,3 (2021): 293-295. doi: https://doi.org/10.22336/rjo.2021.60
Rahhal-Ortuño M, Fernández-Santodomingo AS, Martínez-Rubio C, Barranco-González H, Almor-Palacios I, Rodrigo-Hernández A. Use of plasma rich in growth factors (PRGF-Endoret®) fibrin membrane to cover corneal dellen. Rom J Ophthalmol. 2021 Jul-Sep;65(3):293-295. doi: 10.22336/rjo.2021.60. PMID: 35036656; PMCID: PMC8697786.
Copy Download .nbib Format: NLM
Differential Effects of Mindfulness-Based Intervention Programs at Work on Psychological Wellbeing and Work Engagement.

Frontiers in psychology

Calcagni CC, Salanova M, Llorens S, Bellosta-Batalla M, Martínez-Rubio D, Martínez Borrás R.
PMID: 34646205
Front Psychol. 2021 Sep 27;12:715146. doi: 10.3389/fpsyg.2021.715146. eCollection 2021.

Two different mindfulness-based interventions were deployed in a sample of white-collar workers to explore the differential effects on different facets of mindfulness, dimensions of psychological wellbeing, work engagement, performance, and stress of a participant. A total of 28 participants...

Cite
Calcagni CC, Salanova M, Llorens S, et al. Differential Effects of Mindfulness-Based Intervention Programs at Work on Psychological Wellbeing and Work Engagement. Front Psychol. 2021;12:715146doi: 10.3389/fpsyg.2021.715146.
Calcagni, C. C., Salanova, M., Llorens, S., Bellosta-Batalla, M., Martínez-Rubio, D., & Martínez Borrás, R. (2021). Differential Effects of Mindfulness-Based Intervention Programs at Work on Psychological Wellbeing and Work Engagement. Frontiers in psychology, 12715146. https://doi.org/10.3389/fpsyg.2021.715146
Calcagni, Cristián Coo, et al. "Differential Effects of Mindfulness-Based Intervention Programs at Work on Psychological Wellbeing and Work Engagement." Frontiers in psychology vol. 12 (2021): 715146. doi: https://doi.org/10.3389/fpsyg.2021.715146
Calcagni CC, Salanova M, Llorens S, Bellosta-Batalla M, Martínez-Rubio D, Martínez Borrás R. Differential Effects of Mindfulness-Based Intervention Programs at Work on Psychological Wellbeing and Work Engagement. Front Psychol. 2021 Sep 27;12:715146. doi: 10.3389/fpsyg.2021.715146. eCollection 2021. PMID: 34646205; PMCID: PMC8502863.
Copy Download .nbib Format: NLM
Relationship between immunometabolic status and cognitive performance among major depression disorder patients.

Psychoneuroendocrinology

Sánchez-Carro Y, de la Torre-Luque A, Portella MJ, Leal-Leturia I, Salvat-Pujol N, Massaneda C, de Arriba-Arnau A, Urretavizcaya M, Peretó M, Toll A, Martínez-Ruiz A, Ferreiros-Martinez R, Álvarez P, Soria V, López-García P.
PMID: 34929555
Psychoneuroendocrinology. 2021 Dec 16;137:105631. doi: 10.1016/j.psyneuen.2021.105631. Epub 2021 Dec 16.

BACKGROUND: Alterations in cognitive performance have been described in patients with major depressive disorder (MDD). However, the specific risk factors of these changes are not yet known. This study aimed to explore whether inmunometabolic parameters are related to cognitive...

Cite
Sánchez-Carro Y, de la Torre-Luque A, Portella MJ, et al. Relationship between immunometabolic status and cognitive performance among major depression disorder patients. Psychoneuroendocrinology. 2021;137:105631doi: 10.1016/j.psyneuen.2021.105631.
Sánchez-Carro, Y., de la Torre-Luque, A., Portella, M. J., Leal-Leturia, I., Salvat-Pujol, N., Massaneda, C., de Arriba-Arnau, A., Urretavizcaya, M., Peretó, M., Toll, A., Martínez-Ruiz, A., Ferreiros-Martinez, R., Álvarez, P., Soria, V., & López-García, P. (2021). Relationship between immunometabolic status and cognitive performance among major depression disorder patients. Psychoneuroendocrinology, 137105631. https://doi.org/10.1016/j.psyneuen.2021.105631
Sánchez-Carro, Yolanda, et al. "Relationship between immunometabolic status and cognitive performance among major depression disorder patients." Psychoneuroendocrinology vol. 137 (2021): 105631. doi: https://doi.org/10.1016/j.psyneuen.2021.105631
Sánchez-Carro Y, de la Torre-Luque A, Portella MJ, Leal-Leturia I, Salvat-Pujol N, Massaneda C, de Arriba-Arnau A, Urretavizcaya M, Peretó M, Toll A, Martínez-Ruiz A, Ferreiros-Martinez R, Álvarez P, Soria V, López-García P. Relationship between immunometabolic status and cognitive performance among major depression disorder patients. Psychoneuroendocrinology. 2021 Dec 16;137:105631. doi: 10.1016/j.psyneuen.2021.105631. Epub 2021 Dec 16. PMID: 34929555.
Copy Download .nbib Format: NLM
Relationship between immunometabolic status and cognitive performance among major depression disorder patients.

Psychoneuroendocrinology

Sánchez-Carro Y, de la Torre-Luque A, Portella MJ, Leal-Leturia I, Salvat-Pujol N, Massaneda C, de Arriba-Arnau A, Urretavizcaya M, Peretó M, Toll A, Martínez-Ruiz A, Ferreiros-Martinez R, Álvarez P, Soria V, López-García P.
PMID: 34929555
Psychoneuroendocrinology. 2021 Dec 16;137:105631. doi: 10.1016/j.psyneuen.2021.105631. Epub 2021 Dec 16.

BACKGROUND: Alterations in cognitive performance have been described in patients with major depressive disorder (MDD). However, the specific risk factors of these changes are not yet known. This study aimed to explore whether inmunometabolic parameters are related to cognitive...

Cite
Sánchez-Carro Y, de la Torre-Luque A, Portella MJ, et al. Relationship between immunometabolic status and cognitive performance among major depression disorder patients. Psychoneuroendocrinology. 2021;137:105631doi: 10.1016/j.psyneuen.2021.105631.
Sánchez-Carro, Y., de la Torre-Luque, A., Portella, M. J., Leal-Leturia, I., Salvat-Pujol, N., Massaneda, C., de Arriba-Arnau, A., Urretavizcaya, M., Peretó, M., Toll, A., Martínez-Ruiz, A., Ferreiros-Martinez, R., Álvarez, P., Soria, V., & López-García, P. (2021). Relationship between immunometabolic status and cognitive performance among major depression disorder patients. Psychoneuroendocrinology, 137105631. https://doi.org/10.1016/j.psyneuen.2021.105631
Sánchez-Carro, Yolanda, et al. "Relationship between immunometabolic status and cognitive performance among major depression disorder patients." Psychoneuroendocrinology vol. 137 (2021): 105631. doi: https://doi.org/10.1016/j.psyneuen.2021.105631
Sánchez-Carro Y, de la Torre-Luque A, Portella MJ, Leal-Leturia I, Salvat-Pujol N, Massaneda C, de Arriba-Arnau A, Urretavizcaya M, Peretó M, Toll A, Martínez-Ruiz A, Ferreiros-Martinez R, Álvarez P, Soria V, López-García P. Relationship between immunometabolic status and cognitive performance among major depression disorder patients. Psychoneuroendocrinology. 2021 Dec 16;137:105631. doi: 10.1016/j.psyneuen.2021.105631. Epub 2021 Dec 16. PMID: 34929555.
Copy Download .nbib Format: NLM
Relationship between immunometabolic status and cognitive performance among major depression disorder patients.

Psychoneuroendocrinology

Sánchez-Carro Y, de la Torre-Luque A, Portella MJ, Leal-Leturia I, Salvat-Pujol N, Massaneda C, de Arriba-Arnau A, Urretavizcaya M, Peretó M, Toll A, Martínez-Ruiz A, Ferreiros-Martinez R, Álvarez P, Soria V, López-García P.
PMID: 34929555
Psychoneuroendocrinology. 2021 Dec 16;137:105631. doi: 10.1016/j.psyneuen.2021.105631. Epub 2021 Dec 16.

BACKGROUND: Alterations in cognitive performance have been described in patients with major depressive disorder (MDD). However, the specific risk factors of these changes are not yet known. This study aimed to explore whether inmunometabolic parameters are related to cognitive...

Cite
Sánchez-Carro Y, de la Torre-Luque A, Portella MJ, et al. Relationship between immunometabolic status and cognitive performance among major depression disorder patients. Psychoneuroendocrinology. 2021;137:105631doi: 10.1016/j.psyneuen.2021.105631.
Sánchez-Carro, Y., de la Torre-Luque, A., Portella, M. J., Leal-Leturia, I., Salvat-Pujol, N., Massaneda, C., de Arriba-Arnau, A., Urretavizcaya, M., Peretó, M., Toll, A., Martínez-Ruiz, A., Ferreiros-Martinez, R., Álvarez, P., Soria, V., & López-García, P. (2021). Relationship between immunometabolic status and cognitive performance among major depression disorder patients. Psychoneuroendocrinology, 137105631. https://doi.org/10.1016/j.psyneuen.2021.105631
Sánchez-Carro, Yolanda, et al. "Relationship between immunometabolic status and cognitive performance among major depression disorder patients." Psychoneuroendocrinology vol. 137 (2021): 105631. doi: https://doi.org/10.1016/j.psyneuen.2021.105631
Sánchez-Carro Y, de la Torre-Luque A, Portella MJ, Leal-Leturia I, Salvat-Pujol N, Massaneda C, de Arriba-Arnau A, Urretavizcaya M, Peretó M, Toll A, Martínez-Ruiz A, Ferreiros-Martinez R, Álvarez P, Soria V, López-García P. Relationship between immunometabolic status and cognitive performance among major depression disorder patients. Psychoneuroendocrinology. 2021 Dec 16;137:105631. doi: 10.1016/j.psyneuen.2021.105631. Epub 2021 Dec 16. PMID: 34929555.
Copy Download .nbib Format: NLM
Relationship between immunometabolic status and cognitive performance among major depression disorder patients.

Psychoneuroendocrinology

Sánchez-Carro Y, de la Torre-Luque A, Portella MJ, Leal-Leturia I, Salvat-Pujol N, Massaneda C, de Arriba-Arnau A, Urretavizcaya M, Peretó M, Toll A, Martínez-Ruiz A, Ferreiros-Martinez R, Álvarez P, Soria V, López-García P.
PMID: 34929555
Psychoneuroendocrinology. 2021 Dec 16;137:105631. doi: 10.1016/j.psyneuen.2021.105631. Epub 2021 Dec 16.

BACKGROUND: Alterations in cognitive performance have been described in patients with major depressive disorder (MDD). However, the specific risk factors of these changes are not yet known. This study aimed to explore whether inmunometabolic parameters are related to cognitive...

Cite
Sánchez-Carro Y, de la Torre-Luque A, Portella MJ, et al. Relationship between immunometabolic status and cognitive performance among major depression disorder patients. Psychoneuroendocrinology. 2021;137:105631doi: 10.1016/j.psyneuen.2021.105631.
Sánchez-Carro, Y., de la Torre-Luque, A., Portella, M. J., Leal-Leturia, I., Salvat-Pujol, N., Massaneda, C., de Arriba-Arnau, A., Urretavizcaya, M., Peretó, M., Toll, A., Martínez-Ruiz, A., Ferreiros-Martinez, R., Álvarez, P., Soria, V., & López-García, P. (2021). Relationship between immunometabolic status and cognitive performance among major depression disorder patients. Psychoneuroendocrinology, 137105631. https://doi.org/10.1016/j.psyneuen.2021.105631
Sánchez-Carro, Yolanda, et al. "Relationship between immunometabolic status and cognitive performance among major depression disorder patients." Psychoneuroendocrinology vol. 137 (2021): 105631. doi: https://doi.org/10.1016/j.psyneuen.2021.105631
Sánchez-Carro Y, de la Torre-Luque A, Portella MJ, Leal-Leturia I, Salvat-Pujol N, Massaneda C, de Arriba-Arnau A, Urretavizcaya M, Peretó M, Toll A, Martínez-Ruiz A, Ferreiros-Martinez R, Álvarez P, Soria V, López-García P. Relationship between immunometabolic status and cognitive performance among major depression disorder patients. Psychoneuroendocrinology. 2021 Dec 16;137:105631. doi: 10.1016/j.psyneuen.2021.105631. Epub 2021 Dec 16. PMID: 34929555.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 57 entries